Sign In

Christopher M. Weghorst PhD

Christopher M. Weghorst PhD
ProfessorCollege of Public Healthweghorst.2@osu.edu
M110 Starling Loving Hall 320 W 10th Avenue Columbus OH 43210
Phone:614-293-8441Fax: 614-293-7710
  • Molecular Carcinogenesis and Chemoprevention

General Research Interest

Molecular carcinogenesis and cancer chemoprevention of oral cancer.

Research Description

Dr. Weghorst and his research team are recognized nationally as a leader in the areas molecular and comparative carcinogenesis, focusing on the biological mechanisms, genetic susceptibility and chemoprevention of head and neck and cervical cancer development. His research program has three primary areas of research: i) genetic susceptibility of cancer, ii) food-based cancer prevention and iii) the translational assessment of prevention approaches in human clinical trials.

Current Publications

  • Li J, Knobloch TJ, Poi MJ, Zhang Z, Davis AT, Muscarella P, Weghorst CMGenetic alterations of RD(INK4/ARF) enhancer in human cancer cells.Mol Carcinog in press 10/12/2012
  • Pereira MA, Warner BM, Knobloch TJ, Weghorst CM, Lubet RA, Steele VE, Casto BCChemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.Int J Cancer 131(6) 1277-86 9/15/2012
  • Zhang Z, Knobloch TJ, Seamon LG, Stoner GD, Cohn DE, Paskett ED, Fowler JM, Weghorst CMA black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells.Gynecol Oncol 123(2) 401-6 11/1/2011
  • Accurso BT, Warner BM, Knobloch TJ, Weghorst CM, Shumway BS, Allen CM, Kalmar JRAllelic imbalance in oral lichen planus and assessment of its classification as a premalignant condition.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(3) 359-66 9/1/2011
  • Li J, Knobloch TJ, Kresty LA, Zhang Z, Lang JC, Schuller DE, Weghorst CMGankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer.Anticancer Res 31(9) 2683-92 9/1/2011